Abstract
Introduction: Squamous cell carcinoma of oral cavity is a morphological heterogenous disease. Cytokeratin (CK) comprises a diverse group of intermediate filament protein that are expressed as pairs in both keratinized and non keratinized epithelial tissue. Very little is known of CK alteration in oral intraepithelial neoplasia III (OIN III) and invasive squamous cell carcinoma (SCC).The aim of the study is to evaluate the expression pattern of CK8/18 in oral carcinoma and to establish any correlation between the expressions of CK8/18 with tumor differentiation. Material and Methods: A total of 104 cases of Paraffin embedded formalin fixed sections from oral squamous cell carcinomas (N=60) including benign and inflammatory lesions (control;N=40) and oral intraepithethelial lesions(N=4) were stained with Haematoxylin and eosin stain and and then studied immunohistochemically using CK8 and CK18 immunomarkers. Result: Out of 60 cases of invasive squamous carcinomas, cytokeratin 8 showed positivity in 34 cases (56.67%) while expression of cytokeratin 18 was observed in 25 cases(41.67%) but its expression were absent in control and oral intraepithelial cases. Expression of CK 8 was seen in majority of poorly differentiated 4/5(80%) followed by moderately differentiated 12/17(70.59%), with its expression were significantly higher (56.67%) in invasive oral carcinomas compared with controls statistically .Similarly CK18 expression was seen in majority of poorly 4/5 (80%) followed by moderately differentiated squamous cell carcinomas 7/17(41.18%). Conclusion: Aberrant expression of CK8/18 could be correlated with differentiation and recurrence and shows a great promise to be used as prognostic marker for human oral cancer.
Highlights
Squamous cell carcinoma of oral cavity is a morphological heterogenous disease
Out of total 104 cases, 40 cases (38.46%) were classified as benign and inflammatory lesions that served as control, 4 cases (3.85%) as oral epithelial dysplasia grade III (OIN III) and 60 cases (57.69%) were of invasive squamous cell carcinomas
Available online at: www.pathologyreview.in 83 | P a g e was seen in control and oral intraepithelial lesions while cytokeratin 18 was expressed in 25 cases (41.67%) out of 60 cases of invasive squamous cell carcinomas with maximum intensity seen in 5/60 (8.34%) cases and its expression was absent in all the benign cases as well as in oral intraepithelial lesions. (Figure 1,2,3)
Summary
Squamous cell carcinoma of oral cavity is a morphological heterogenous disease. Cytokeratin (CK) comprises a diverse group of intermediate filament protein that are expressed as pairs in both keratinized and non keratinized epithelial tissue. Result: Out of 60 cases of invasive squamous carcinomas, cytokeratin 8 showed positivity in 34 cases (56.67%) while expression of cytokeratin 18 was observed in 25 cases (41.67%) but its expression were absent in control and oral intraepithelial cases. Expression of CK 8 was seen in majority of poorly differentiated 4/5 (80%) followed by moderately differentiated 12/17 (70.59%), with its expression were significantly higher (56.67%) in invasive oral carcinomas compared with controls statistically. CK18 expression was seen in majority of poorly 4/5 (80%) followed by moderately differentiated squamous cell carcinomas 7/17 (41.18%). Oral carcinoma represents a major global health problem. It is the sixth most frequently diagnosed malignancy with high incidence of mortality and morbidity [1].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
